What happens when a scientist, engineer, and VC see the same future — one where data and biology converge to change medicine?

In this episode of The Russo Edge, Sahir Ali, Founder and General Partner of Modi Ventures, joins Solomon Wilcots to discuss how artificial intelligence and data are reshaping the business of biotech. Drawing on his background across programming, Wall Street, and cancer research, Sahir explains how his firm uses a portfolio theory approach to manage risk, identify value, and back the next generation of healthcare breakthroughs.

From AI-enabled discovery to Houston’s fast-growing life sciences hub, Sahir offers a window into how venture capital is evolving — and how data-driven strategies can create smarter, more sustainable innovation in biotech.

In this episode of The Russo Edge, two leading journalists pull back the curtain on how science becomes a headline. Heather McKenzie, Senior Editor at BioSpace and Ben Glickman, Reporter at The Wall Street Journal, join host Solomon Wilcots to share what earns their attention, what builds trust, and what turns them off before a single question is asked.

Together, they break down how biotech companies can communicate complex data with clarity, why timing is everything when engaging in the press, and how credibility can be strengthened long before a major announcement. From background conversations to clear trial summaries and investor context, this conversation offers practical, real-world advice for biotech leaders.

What if the earliest chapters of lifelong health are written in the gut — before a child even reaches preschool? Modern babies are often born without key microbes that train the immune system, leaving them more vulnerable to chronic conditions like allergies, asthma, and eczema.

This episode of The Russo Edge, Dr. Stephanie Culler, Co-founder and CEO of Persephone Biosciences, explains what makes the infant gut unique, why nine out of ten U.S. babies are born with microbiome deficiencies, and how her team is developing a synbiotic designed to replenish what’s lost.

From cancer research to dirty diapers, this is an entrepreneur's story of resilience, humor, and groundbreaking science — and why the smallest organisms in our gut may hold the biggest key to lifelong wellness.